Ready-to-wear clothing.

Retail services connected with the sale of clothing and clothing accessories;Retail services in relation to fashion accessories;Fashion show exhibitions for commercial purposes;Promoting the sale of fashion goods through promotional articles in magazines;Fashion shows for promotional purposes (Organization of -);Organization of fashion shows for promotional purposes;Organisation of fashion shows for commercial purposes;Organization of fashion parades for sales promotion purposes.

Apparatus for coating and paint-spraying technology; flow heaters and drum heaters; all the aforesaid goods exclusively for use in the field of coating and paint-spraying technology.

Sales of lifting and hoisting apparatus, hydraulic lifts and hydraulic work platforms, self-propelled lifting and hoisting apparatus, self-propelled hydraulic lifts and self-propelled hydraulic work platforms, vehicles with hydraulic lifts, hydraulic work platforms, lifting or hoisting apparatus and parts and fittings for the aforesaid goods.

Assembly and installation work, assembly supervision in connection with the aforesaid goods in classes 7 and 12; Maintenance, repair, servicing and general overhaul in connection with the aforesaid goods in classes 7 and 12; Painting of surfaces.

Engineering, building and construction consultancy, building and construction drafting, technical consultancy, conducting of technical inspections, certifications, testing on prototypes and initial models of the aforesaid goods or in connection with the aforesaid goods, material testing.

Stretchers; medical devices, equipment and apparatus.

Jewellery; watches; dog tags.

Printed matter; instructional materials.

Bags and rucksacks.

Structural panels; anti-ballistic structural panels; blast resistant structural panels; armour panels.

Clothing; footwear; headgear.

Custom manufacture of pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; custom manufacture of RNAi-based pharmaceuticals and medicines; custom manufacture of short interfering RNA (siRNA) medicines; custom manufacture of nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression; custom manufacture of pharmaceutical and medical preparations for use in targeting messenger RNA (mRNA) and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid.

Scientific research and development in the field of targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to RNAi-based pharmaceuticals and medicines; scientific, pharmaceutical and medical research and development services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific, pharmaceutical and medical research and development services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking gene expression, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and, pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; drug discovery services relating to RNAi-based pharmaceuticals and medicines; drug discovery services relating to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; drug discovery services relating to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; scientific and technical testing and data analysis in relation to pharmaceuticals and medicines; scientific and technical testing and data analysis in relation to RNAibased medicines; scientific and technical testing and data analysis in relation to pharmaceutical and medical preparations for use in targeting genes and blocking, silencing or inhibiting gene expression; scientific and technical testing and data analysis in relation to short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design, development, creation and maintenance of computer platforms and computer software for use in the field of pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer platforms and computer software enabling the searching and retrieval of data relating to pharmaceuticals, medicines and drug discovery; design, development, creation and maintenance of computer platforms and computer software for the analysis of data relating to pharmaceuticals, medicines and drug discovery; design, provision and operation of search engine software for use in the field of pharmaceuticals, medicines and drug discovery; design, provision and operation of search engine software for the searching, retrieval, indexing and analysis of data relating to pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery; Platform as a Service (PaaS) services relating to the use of artificial intelligence and machine learning software and databases in relation to RNAi-based medicines and pharmaceuticals, short interfering RNA (siRNA) medicines, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; design and development of computer-simulated models for use in the field of pharmaceuticals, medicines and drug discovery; nondownloadable computer software for use in the field of pharmaceuticals, medicines and drug discovery, namely, for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning software and databases in the field of pharmaceuticals, medicines and drug discovery, namely, for evaluating, analysing, and interpreting information contained in databases to identify new biological targets and gene-disease associations; Software as a Service (SaaS) services relating to the use of artificial intelligence and machine learning in relation to RNAi-based medicines and pharmaceuticals, nucleic acid-based drugs (NABDs) for blocking, silencing or inhibiting gene expression, and pharmaceutical and medical preparations for use in targeting mRNA and triggering its degradation; provision of information, advice and consultancy services relating to all of the aforesaid.